Summary
RPG Life Sciences' subsidiary, RPG Active Pharma, is acquiring Raghava Life Sciences' API and intermediates business for Rs 135 crore. This strategic acquisition aims to enhance RPG Active Pharma's integrated API capabilities and manufacturing footprint, including 22 commercialized APIs and seven development-stage assets.